Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 946 AL 960

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics

Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, Manczak M.

Biochim Biophys Acta. 2012 May;1822(5):639-49. doi: 10.1016/j.bbadis.2011.10.011. Epub 2011 Oct 19.

Psychometric evaluation of the Swedish version of the Person-Centered Care Assessment Tool (P-CAT)

Sjögren K, Lindkvist M, Sandman PO, Zingmark K, Edvardsson D.

Int Psychogeriatr. 2012 Mar;24(3):406-15. doi: 10.1017/S104161021100202X. Epub 2011 Nov 1.

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

Geerts H.

Expert Opin Investig Drugs. 2012 Jan;21(1):59-65. doi: 10.1517/13543784.2012.633510. Epub 2011 Nov 3.

Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Kokjohn TA, Maarouf CL, Roher AE.

Alzheimers Dement. 2012 Nov;8(6):574-83. doi: 10.1016/j.jalz.2011.05.2429. Epub 2011 Nov 2.

Neurological diseases and pain

Borsook D.

Brain. 2012 Feb;135(Pt 2):320-44. doi: 10.1093/brain/awr271. Epub 2011 Nov 8.

Amelioration of amyloid β-induced cognitive deficits by Zataria multiflora Boiss. essential oil in a rat model of Alzheimer's disease

Majlessi N, Choopani S, Kamalinejad M, Azizi Z.

CNS Neurosci Ther. 2012 Apr;18(4):295-301. doi: 10.1111/j.1755-5949.2011.00237.x. Epub 2011 Feb 16.

Systemic and central immunity in Alzheimer's disease: therapeutic implications

Butchart J, Holmes C.

CNS Neurosci Ther. 2012 Jan;18(1):64-76. doi: 10.1111/j.1755-5949.2011.00245.x. Epub 2011 Mar 21.

Recent rodent models for Alzheimer's disease: clinical implications and basic research

Braidy N, Muñoz P, Palacios AG, Castellano-Gonzalez G, Inestrosa NC, Chung RS, Sachdev P, Guillemin GJ.

J Neural Transm (Vienna). 2012 Feb;119(2):173-95. doi: 10.1007/s00702-011-0731-5. Epub 2011 Nov 16.

Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial

Ihl R, Tribanek M, Bachinskaya N; GOTADAY Study Group.

Pharmacopsychiatry. 2012 Mar;45(2):41-6. doi: 10.1055/s-0031-1291217. Epub 2011 Nov 15.

Hippocampal subregions are differentially affected in the progression to Alzheimer's disease

Greene SJ, Killiany RJ; Alzheimer's Disease Neuroimaging Initiative.

Anat Rec (Hoboken). 2012 Jan;295(1):132-40. doi: 10.1002/ar.21493. Epub 2011 Nov 18.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer’s Association.

Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.

Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin

Rosales-Corral SA, Acuña-Castroviejo D, Coto-Montes A, Boga JA, Manchester LC, Fuentes-Broto L, Korkmaz A, Ma S, Tan DX, Reiter RJ.

J Pineal Res. 2012 Mar;52(2):167-202. doi: 10.1111/j.1600-079X.2011.00937.x. Epub 2011 Nov 23.

Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics

de Waal H, Stam CJ, de Haan W, van Straaten EC, Scheltens P, van der Flier WM.

Neurobiol Aging. 2012 May;33(5):1008.e25-31. doi: 10.1016/j.neurobiolaging.2011.10.013. Epub 2011 Nov 26.

Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease

Goos JD, Teunissen CE, Veerhuis R, Verwey NA, Barkhof F, Blankenstein MA, Scheltens P, van der Flier WM.

Neurobiol Aging. 2012 May;33(5):1011.e1-9. doi: 10.1016/j.neurobiolaging.2011.10.026. Epub 2011 Nov 26.

MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease

Schonrock N, Matamales M, Ittner LM, Götz J.

Exp Neurol. 2012 Jun;235(2):447-54. doi: 10.1016/j.expneurol.2011.11.013. Epub 2011 Nov 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias